ID

40508

Beschreibung

A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA); ODM derived from: https://clinicaltrials.gov/show/NCT01544114

Link

https://clinicaltrials.gov/show/NCT01544114

Stichworte

Versionen (1)
  1. 28.04.20 28.04.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

28. April 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Juvenile Idiopathic Arthritis (JIA) NCT01544114

Englisch

Eligibility Juvenile Idiopathic Arthritis (JIA) NCT01544114

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
parent or legal guardian is able to provide written informed consent and patient is able to provide written assent if appropriate.
Beschreibung

Informed Consent Parent | Informed Consent Legal Guardian | Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0030551
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0023226
UMLS CUI [3]
C0021430
male and female adolescents aged 12 to 16 years at the time of enrollment.
Beschreibung

Adolescent | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0205653
UMLS CUI [2]
C0001779
diagnosed with jia, including all the ilar jia subtypes: oligoarthritis, polyarthritis (both rf+ and rf-), psoriatic arthritis, enthesitis-related arthritis,undifferentiated arthritis, and systemic arthritis.
Beschreibung

Juvenile arthritis | Oligoarticular Arthritis | Polyarthritis Rheumatoid factor positive | Polyarthritis Rheumatoid factor negative | Arthritis, Psoriatic | Enthesitis-Related Arthritis | Undifferentiated Juvenile Idiopathic Arthritis | Systemic onset juvenile chronic arthritis

Datentyp

boolean

Alias
UMLS CUI [1]
C3495559
UMLS CUI [2]
C3892044
UMLS CUI [3,1]
C0162323
UMLS CUI [3,2]
C0151379
UMLS CUI [4,1]
C0162323
UMLS CUI [4,2]
C0427391
UMLS CUI [5]
C0003872
UMLS CUI [6]
C3495919
UMLS CUI [7]
C3897245
UMLS CUI [8]
C1384600
based upon investigator judgment, it is determined appropriate for the patient to undergo 6 months of continuous treatment with vimovo.
Beschreibung

Vimovo

Datentyp

boolean

Alias
UMLS CUI [1]
C2918032
body weight >31 kg (68.2 lbs) and within the 5th to 95th percentile of body mass index for age.
Beschreibung

Body Weight | Body mass index percentile per age

Datentyp

boolean

Alias
UMLS CUI [1]
C0005910
UMLS CUI [2]
C3838397
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
in systemic jia patients, presence of systemic features (ie, fever, rheumatoid rash, serositis, lymphadenopathy, macrophage activation syndrome) within 6 months prior to start of study drug.
Beschreibung

Systemic onset juvenile chronic arthritis | Feature Systemic | Fever | Exanthema | Other Coding | Serositis | Lymphadenopathy | Macrophage Activation Syndrome

Datentyp

boolean

Alias
UMLS CUI [1]
C1384600
UMLS CUI [2,1]
C2348519
UMLS CUI [2,2]
C0205373
UMLS CUI [3]
C0015967
UMLS CUI [4]
C0015230
UMLS CUI [5]
C3846158
UMLS CUI [6]
C0036749
UMLS CUI [7]
C0497156
UMLS CUI [8]
C1096155
currently taking (ie, within 4 weeks prior to start of drug) naproxen >20 mg/kg/day or >1000 mg total daily dose.
Beschreibung

Naproxen U/day

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027396
UMLS CUI [1,2]
C0456683
hemoglobin ≤8.5 g/dl.
Beschreibung

Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0518015
individuals who have cardiovascular or cerebrovascular disease, based on history or risk factors.
Beschreibung

Cardiovascular Disease | Cerebrovascular Disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0007820
any significant hepatic, renal, pulmonary, ophthalmologic, neurologic, or any other medical conditions indicated by medical/surgical history, physical, or laboratory examination that might put the patient at greater risk during the study.
Beschreibung

Liver diseases | Kidney Diseases | Lung diseases | Disorder of eye | Nervous system disorder | Other medical condition At risk Patient | Medical History | History of prior surgery | Physical Examination | Laboratory examination

Datentyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0024115
UMLS CUI [4]
C0015397
UMLS CUI [5]
C0027765
UMLS CUI [6,1]
C3843040
UMLS CUI [6,2]
C1444641
UMLS CUI [6,3]
C0030705
UMLS CUI [7]
C0262926
UMLS CUI [8]
C0744961
UMLS CUI [9]
C0031809
UMLS CUI [10]
C0260877
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Juvenile Idiopathic Arthritis (JIA) NCT01544114

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent Parent | Informed Consent Legal Guardian | Informed Consent
Item
parent or legal guardian is able to provide written informed consent and patient is able to provide written assent if appropriate.
boolean
C0021430 (UMLS CUI [1,1])
C0030551 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0023226 (UMLS CUI [2,2])
C0021430 (UMLS CUI [3])
Adolescent | Age
Item
male and female adolescents aged 12 to 16 years at the time of enrollment.
boolean
C0205653 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Juvenile arthritis | Oligoarticular Arthritis | Polyarthritis Rheumatoid factor positive | Polyarthritis Rheumatoid factor negative | Arthritis, Psoriatic | Enthesitis-Related Arthritis | Undifferentiated Juvenile Idiopathic Arthritis | Systemic onset juvenile chronic arthritis
Item
diagnosed with jia, including all the ilar jia subtypes: oligoarthritis, polyarthritis (both rf+ and rf-), psoriatic arthritis, enthesitis-related arthritis,undifferentiated arthritis, and systemic arthritis.
boolean
C3495559 (UMLS CUI [1])
C3892044 (UMLS CUI [2])
C0162323 (UMLS CUI [3,1])
C0151379 (UMLS CUI [3,2])
C0162323 (UMLS CUI [4,1])
C0427391 (UMLS CUI [4,2])
C0003872 (UMLS CUI [5])
C3495919 (UMLS CUI [6])
C3897245 (UMLS CUI [7])
C1384600 (UMLS CUI [8])
Vimovo
Item
based upon investigator judgment, it is determined appropriate for the patient to undergo 6 months of continuous treatment with vimovo.
boolean
C2918032 (UMLS CUI [1])
Body Weight | Body mass index percentile per age
Item
body weight >31 kg (68.2 lbs) and within the 5th to 95th percentile of body mass index for age.
boolean
C0005910 (UMLS CUI [1])
C3838397 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Systemic onset juvenile chronic arthritis | Feature Systemic | Fever | Exanthema | Other Coding | Serositis | Lymphadenopathy | Macrophage Activation Syndrome
Item
in systemic jia patients, presence of systemic features (ie, fever, rheumatoid rash, serositis, lymphadenopathy, macrophage activation syndrome) within 6 months prior to start of study drug.
boolean
C1384600 (UMLS CUI [1])
C2348519 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0015967 (UMLS CUI [3])
C0015230 (UMLS CUI [4])
C3846158 (UMLS CUI [5])
C0036749 (UMLS CUI [6])
C0497156 (UMLS CUI [7])
C1096155 (UMLS CUI [8])
Naproxen U/day
Item
currently taking (ie, within 4 weeks prior to start of drug) naproxen >20 mg/kg/day or >1000 mg total daily dose.
boolean
C0027396 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Hemoglobin measurement
Item
hemoglobin ≤8.5 g/dl.
boolean
C0518015 (UMLS CUI [1])
Cardiovascular Disease | Cerebrovascular Disorder
Item
individuals who have cardiovascular or cerebrovascular disease, based on history or risk factors.
boolean
C0007222 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
Liver diseases | Kidney Diseases | Lung diseases | Disorder of eye | Nervous system disorder | Other medical condition At risk Patient | Medical History | History of prior surgery | Physical Examination | Laboratory examination
Item
any significant hepatic, renal, pulmonary, ophthalmologic, neurologic, or any other medical conditions indicated by medical/surgical history, physical, or laboratory examination that might put the patient at greater risk during the study.
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0024115 (UMLS CUI [3])
C0015397 (UMLS CUI [4])
C0027765 (UMLS CUI [5])
C3843040 (UMLS CUI [6,1])
C1444641 (UMLS CUI [6,2])
C0030705 (UMLS CUI [6,3])
C0262926 (UMLS CUI [7])
C0744961 (UMLS CUI [8])
C0031809 (UMLS CUI [9])
C0260877 (UMLS CUI [10])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video